New expert committee to consult on drug pricing, new drug launches
Department of pharmaceuticals has clearly defined the terms of reference for the committee, citing that the new committee be entrusted to deliberate and recommend its opinion on the claims of pharma industry
- The department of pharmaceuticals (DoP) has set up a committee including experts to assist on matters of pricing and launch of new drugs to help resolve issues in a time-bound manner, as reported livemint.com.
- The committee, which will include experts from India’s National Pharmaceutical Pricing Authority (NPPA), scientists, department of health research under the ministry of health and family welfare, representatives from the Central Drugs Standard Control Organisation (CDSCO), will work on issues between the industry and the government.
“In view of the experience gained from implementation of Drugs (Prices control) order 2013, it has been decided to constitute a single multi-disciplinary committee of experts for consultation on all technical issues related to pricing, launch of new drugs etc. where more clarity may be required and opine on matters referred to it by NPPA on discharge of its functions,” noted the DoP’s order.